2nd Non-Viral RNA Delivery Systems Summit

As the first and only industry-led forum dedicated to tackling the most pressing challenges when delivering RNA-based drugs, the 2nd Annual Non-Viral RNA Delivery Systems Summit is set to unite 50+ key thought leaders in biopharma and academia eager to help RNA vaccines and therapeutics reach their medical potential.

Hear from 18+ expert speakers across 3 days of data-driven presentations, technical workshops, and panel discussions to accelerate formulation, promote cell specificity, manipulate immunogenicity, whilst uncovering the latest delivery vehicles revolutionizing targeted RNA delivery.

URLs:
Website: https://go.evvnt.com/1837142-0?pid=10018
Tickets: https://go.evvnt.com/1837142-2?pid=10018
Brochure: https://go.evvnt.com/1837142-3?pid=10018

Prices:
Drug Developer - Conference + 2 Workshops: USD 4297.00,
Drug Developer - Conference + 1 Workshop: USD 3648.00,
Drug Developer - Conference Only: USD 2999.00,
Academic Pricing - Conference + 2 Workshops: USD 3697.00,
Academic Pricing - Conference + 1 Workshop: USD 3148.00,
Academic Pricing - Conference Only: USD 2599.00,
Solution Provider Pricing - Conference + 2 Workshops: USD 5297.00,
Solution Provider Pricing - Conference + 1 Workshop: USD 4548.00,
Solution Provider Pricing - Conference Only: USD 3799.00

Speakers: Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics, Jaap Rip, Chief Scientific Officer, 20Med Therapeutics, Jasdave Chahal, Co-Founder and Chief Scientist, Tiba Biotech LLC, Jay Kim, CEO, K2B Therapeutics Inc., Jeff Atkinson, Executive Director- Process Development and Analytical Sciences, Omega Therapeutics, Jessica Rouge, Associate Professor, University of Connecticut, Laura Rotolo, Formulation Chemist, Emory University, Liping Zhou, Senior Director - Advanced Drug Delivery, AstraZeneca, Mano Manoharan, Senior Vice President, Alnylam Pharmaceuticals, Manuel Sanchez-Felix, Associate Director, Novartis AG, Merle Fuchs, CEO, Co-Founder, PRAMOMOLECULAR GmbH, Sean Lu, Director of Oligonucleotide Chemistry, Eli Lilly and Co., Sujit Jain, Director - External Manufacturing, SalioGen Therapeutics, Susan Rosenbaum, Founder, Chairman and Chief Executive Officer, Lauren Sciences LLC, Zdravka Medarova, CTO, TransCode Therapeutics Inc.